GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | 8/14/2026 8:15:02 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $5,788,000 | EPS -$0.12 | ||
| GT Biopharma, Inc. (GTBP) | 7/2/2026 4:35:50 PM | View | Proxy | SEC | Y 2025 | ||||||
| GT Biopharma, Inc. (GTBP) | 5/15/2026 8:11:29 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $9,996,000 | EPS -$0.11 | ||
| GT Biopharma, Inc. (GTBP) | 3/6/2026 4:14:22 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2025 ending: 6/30/2025 | Assets $7,124,000 | EPS -$10.92 | ||
| GT Biopharma, Inc. (GTBP) | 3/6/2026 4:14:22 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2025 ending: 9/30/2025 | Assets $4,321,000 | EPS $1.04 | ||
| GT Biopharma, Inc. (GTBP) | 3/2/2026 7:11:51 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $8,106,000 | EPS -$6.68 | ||
| GT Biopharma, Inc. (GTBP) | 11/14/2025 4:12:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $4,321,000 | EPS $1.04 | ||
| GT Biopharma, Inc. (GTBP) | 11/14/2025 9:07:25 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $4,321,000 | EPS $1.04 | Export Earnings Model | ||
| GT Biopharma, Inc. (GTBP) | 8/14/2025 4:14:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $7,124,000 | EPS -$10.92 | ||
| GT Biopharma, Inc. (GTBP) | 6/11/2025 4:32:17 PM | View | Proxy | SEC | Y 2024 | ||||||
| GT Biopharma, Inc. (GTBP) | 5/15/2025 3:43:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $2,658,000 | EPS -$0.33 | ||
| GT Biopharma, Inc. (GTBP) | 4/14/2025 4:14:06 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $4,232,000 | EPS -$6.94 | ||
| GT Biopharma, Inc. (GTBP) | 2/21/2025 5:14:48 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $4,232,000 | EPS -$6.94 | ||
| GT Biopharma, Inc. (GTBP) | 11/14/2024 4:30:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $6,759,000 | EPS -$1.53 | ||
| GT Biopharma, Inc. (GTBP) | 8/14/2024 4:19:35 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $9,267,000 | EPS -$2.17 | ||
| GT Biopharma, Inc. (GTBP) | 5/15/2024 5:19:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $9,912,000 | EPS -$1.64 | ||
| GT Biopharma, Inc. (GTBP) | 4/29/2024 4:08:49 PM | View | Proxy | SEC | Y 2023 | ||||||
| GT Biopharma, Inc. (GTBP) | 3/26/2024 5:16:50 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $14,109,000 | EPS -$5.64 | ||
| GT Biopharma, Inc. (GTBP) | 11/6/2023 5:22:00 PM | View | Proxy | SEC | Y 2022 | ||||||
| GT Biopharma, Inc. (GTBP) | 11/1/2023 9:17:48 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $16,148,000 | EPS -$0.06 | ||
| GT Biopharma, Inc. (GTBP) | 11/1/2023 9:10:11 AM | View | Financials | Earnings | WIRE | 3Q 2023 | Assets $16,148,000 | EPS -$0.06 | Export Earnings Model | ||
| GT Biopharma, Inc. (GTBP) | 8/7/2023 9:44:54 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $18,144,000 | EPS -$0.05 | ||
| GT Biopharma, Inc. (GTBP) | 8/7/2023 9:02:37 AM | View | Financials | Earnings | WIRE | 2Q 2023 | Assets $18,144,000 | EPS -$0.05 | Export Earnings Model | ||
| GT Biopharma, Inc. (GTBP) | 5/15/2023 5:10:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $20,086,000 | |||
| GT Biopharma, Inc. (GTBP) | 5/15/2023 5:01:29 PM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $20,086,000 | Export Earnings Model | |||
| GT Biopharma, Inc. (GTBP) | 5/5/2023 5:29:49 PM | View | Proxy | SEC | Y 2022 | ||||||
| GT Biopharma, Inc. (GTBP) | 5/1/2023 5:28:33 PM | View | Proxy | SEC | Y 2022 | ||||||
| GT Biopharma, Inc. (GTBP) | 3/30/2023 5:07:44 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $16,736,000 | |||
| GT Biopharma, Inc. (GTBP) | 3/30/2023 5:01:40 PM | View | Financials | Earnings | WIRE | Y 2022 | Assets $16,736,000 | Export Earnings Model | |||
| GT Biopharma, Inc. (GTBP) | 10/31/2022 5:35:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $21,071,000 | |||
| GT Biopharma, Inc. (GTBP) | 10/31/2022 5:16:59 PM | View | Financials | Earnings | WIRE | 3Q 2022 | Assets $21,071,000 | Export Earnings Model | |||
| GT Biopharma, Inc. (GTBP) | 8/17/2022 5:01:42 PM | View | Proxy | SEC | Y 2021 | ||||||
| GT Biopharma, Inc. (GTBP) | 8/15/2022 9:48:54 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $24,170,000 | |||
| GT Biopharma, Inc. (GTBP) | 8/11/2022 9:36:55 AM | View | Financials | Earnings | WIRE | 2Q 2022 | Assets $24,170,000 | Export Earnings Model | |||
| GT Biopharma, Inc. (GTBP) | 5/16/2022 9:17:29 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $27,439,000 | |||
| GT Biopharma, Inc. (GTBP) | 5/16/2022 8:03:25 AM | View | Financials | Earnings | WIRE | 1Q 2022 | Assets $27,439,000 | Export Earnings Model | |||
| GT Biopharma, Inc. (GTBP) | 4/29/2022 5:23:14 PM | View | Proxy | SEC | Y 2021 | ||||||
| GT Biopharma, Inc. (GTBP) | 3/28/2022 4:26:03 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $32,169,000 | |||
| GT Biopharma, Inc. (GTBP) | 3/28/2022 4:15:58 PM | View | Financials | Earnings | WIRE | Y 2021 | Assets $32,169,000 | Export Earnings Model | |||
| GT Biopharma, Inc. (GTBP) | 12/29/2021 5:32:20 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2021 ending: 6/30/2021 | Assets $39,567,000 | |||
| GT Biopharma, Inc. (GTBP) | 11/10/2021 5:23:03 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $35,798,000 | |||
| GT Biopharma, Inc. (GTBP) | 11/10/2021 4:12:55 PM | View | Financials | Earnings | WIRE | 2Q 2021 | Assets $39,567,000 | Export Earnings Model | |||
| GT Biopharma, Inc. (GTBP) | 8/23/2021 4:42:12 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $39,567,000 | |||
| GT Biopharma, Inc. (GTBP) | 5/17/2021 5:33:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $27,643,000 | |||
| GT Biopharma, Inc. (GTBP) | 4/16/2021 5:22:39 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $5,661,000 | EPS -$6.45 | ||
| GT Biopharma, Inc. (GTBP) | 1/14/2021 5:02:53 PM | View | Proxy | SEC | Y 2020 | ||||||
| GT Biopharma, Inc. (GTBP) | 11/13/2020 5:16:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $917,000 | EPS -$0.64 | ||
| GT Biopharma, Inc. (GTBP) | 8/18/2020 6:12:43 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2020 ending: 6/30/2020 | Assets $1,063,000 | EPS -$4.12 | ||
| GT Biopharma, Inc. (GTBP) | 8/14/2020 5:15:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $1,063,000 | EPS -$4.12 | ||
| GT Biopharma, Inc. (GTBP) | 5/15/2020 4:56:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $295,000 | EPS -$0.02 | ||
| GT Biopharma, Inc. (GTBP) | 3/27/2020 4:15:08 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $396,000 | EPS -$0.01 | ||
| GT Biopharma, Inc. (GTBP) | 11/14/2019 4:25:14 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $482,000 | EPS -$0.51 | ||
| GT Biopharma, Inc. (GTBP) | 8/14/2019 4:40:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $25,707,000 | EPS -$0.05 | ||
| GT Biopharma, Inc. (GTBP) | 5/15/2019 4:34:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $25,539,000 | EPS -$0.51 | ||
| GT Biopharma, Inc. (GTBP) | 3/29/2019 4:32:46 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $25,399,000 | EPS -$5.16 | ||
| GT Biopharma, Inc. (GTBP) | 11/15/2018 8:03:23 AM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $26,536,000 | EPS -$4.70 | Export Earnings Model | ||
| GT Biopharma, Inc. (GTBP) | 11/14/2018 6:25:34 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $26,536,000 | EPS -$4.70 | ||
| GT Biopharma, Inc. (GTBP) | 8/15/2018 4:00:41 AM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $255,014,000 | EPS $50,117,977.00 | ||
| GT Biopharma, Inc. (GTBP) | 5/29/2018 4:00:16 AM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $257,333,000 | EPS -$0.20 | ||
| GT Biopharma, Inc. (GTBP) | 3/1/2018 5:22:33 PM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $254,368,000 | EPS -$8.60 | ||
| GT Biopharma, Inc. (GTBP) | 2/28/2018 6:45:11 PM | Micro | View | Financials | 10-K/A | SEC | Y 2016 ending: 12/31/2016 | Assets $25,000 | EPS $119.91 | ||
| GT Biopharma, Inc. (GTBP) | 2/28/2018 6:45:11 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2016 ending: 9/30/2016 | Assets $160,000 | EPS $0.13 | ||
| GT Biopharma, Inc. (GTBP) | 2/28/2018 6:45:11 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2016 ending: 6/30/2016 | Assets $362,000 | EPS $0.06 | ||
| GT Biopharma, Inc. (GTBP) | 2/28/2018 6:45:11 PM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2016 ending: 3/31/2016 | Assets $37,000 | EPS $0.84 | ||
| GT Biopharma, Inc. (GTBP) | 2/28/2018 6:45:10 PM | Micro | View | Financials | 10-K/A | SEC | Y 2015 ending: 12/31/2015 | Rev: $27,000 -55.7% | Assets $54,000 | EPS -$8.96 | |
| GT Biopharma, Inc. (GTBP) | 11/14/2017 4:25:17 PM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $256,520,000 | EPS -$8.15 | ||
| GT Biopharma, Inc. (GTBP) | 8/11/2017 4:54:43 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $42,000 | EPS $479,053.00 | ||
| OXIS INTERNATIONAL INC (GTBP) | 5/12/2017 4:02:03 PM | View | Proxy | SEC | Y 2016 | ||||||
| OXIS INTERNATIONAL INC (GTBP) | 4/28/2017 4:33:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $238,000 | EPS -$26.36 | ||
| OXIS INTERNATIONAL INC (GTBP) | 3/31/2017 4:06:13 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $25,000 | EPS $119.91 | ||
| OXIS INTERNATIONAL INC (GTBP) | 11/14/2016 5:13:03 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $160,000 | EPS $0.13 | ||
| OXIS INTERNATIONAL INC (GTBP) | 8/10/2016 4:06:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $362,000 | EPS $0.06 | ||
| OXIS INTERNATIONAL INC (GTBP) | 5/13/2016 5:17:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $37,000 | EPS $0.84 | ||
| OXIS INTERNATIONAL INC (GTBP) | 3/30/2016 5:01:56 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $27,000 -55.7% | Assets $54,000 | EPS -$8.96 | |
| OXIS INTERNATIONAL INC (GTBP) | 11/13/2015 5:15:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $49,000 | EPS $0.71 | ||
| OXIS INTERNATIONAL INC (GTBP) | 8/14/2015 4:30:38 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $20,000 -20.0% | Assets $132,000 | EPS $5.47 | |
| OXIS INTERNATIONAL INC (GTBP) | 5/19/2015 5:17:48 PM | View | Proxy | SEC | Y 2014 | ||||||
| OXIS INTERNATIONAL INC (GTBP) | 5/14/2015 4:00:37 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $7,000 | Assets $1,425,000 | EPS -$8.61 | |
| OXIS INTERNATIONAL INC (GTBP) | 3/31/2015 4:00:58 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $61,000 -83.4% | Assets $888,000 | EPS -$0.04 | |
| OXIS INTERNATIONAL INC (GTBP) | 1/8/2015 5:03:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $3,000 -98.4% | Assets $710,000 | EPS -$0.01 | |
| OXIS INTERNATIONAL INC (GTBP) | 1/8/2015 5:02:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $25,000 -86.3% | Assets $52,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 1/8/2015 5:01:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $103,000 | |||
| OXIS INTERNATIONAL INC (GTBP) | 1/8/2015 3:53:37 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $368,000 +7.6% | Assets $147,000 | EPS -$0.01 | |
| OXIS INTERNATIONAL INC (GTBP) | 12/17/2014 4:52:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $183,000 +52.5% | Assets $62,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 12/12/2014 4:40:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $183,000 +18,200.0% | Assets $154,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 12/10/2014 4:52:35 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $88,000 +8,700.0% | Assets $118,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 11/18/2014 5:00:59 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $342,000 +1,215.4% | Assets $226,000 | EPS -$0.01 | |
| OXIS INTERNATIONAL INC (GTBP) | 11/21/2012 3:27:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $120,000 +5,900.0% | Assets $88,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 9/13/2012 1:19:13 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $1,000 0.0% | Assets $125,000 | EPS -$0.01 | |
| OXIS INTERNATIONAL INC (GTBP) | 5/21/2012 2:25:54 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $1,000 -95.0% | Assets $166,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 4/16/2012 4:52:30 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $26,000 +136.4% | Assets $129,000 | EPS -$0.02 | |
| OXIS INTERNATIONAL INC (GTBP) | 11/21/2011 4:30:52 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $2,000 | Assets $371,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 9/12/2011 5:30:00 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $1,000 | Assets $228,000 | ||
| OXIS INTERNATIONAL INC (GTBP) | 1/19/2011 7:06:00 PM | View | Proxy | SEC | Y 2010 |